SearchResearch
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED)

Request Access

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.

O. Vardeny, KyungMann Kim, J. Udell, et al. (2020). JAMA. Cited 101 times. https://doi.org/10.1001/jama.2020.23649

High‐dose influenza vaccine to reduce clinical outcomes in high‐risk cardiovascular patients: Rationale and design of the INVESTED trial☆☆

O. Vardeny, J. Udell, J. Joseph, et al. (2018). American Heart Journal. Cited 42 times. https://doi.org/10.1016/j.ahj.2018.05.007

Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease

A. Peikert, B. Claggett, Jacob A. Udell, et al. (2024). JAMA Cardiology. Cited 14 times. https://doi.org/10.1001/jamacardio.2024.0468

Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial

A. Peikert, B. Claggett, Kyungeun Kim, et al. (2022). European Journal of Heart Failure. Cited 10 times. https://doi.org/10.1002/ejhf.2716

Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease

Sheila M. Hegde, B. Claggett, Jacob A. Udell, et al. (2023). JAMA Network Open. Cited 6 times. https://doi.org/10.1001/jamanetworkopen.2023.31284

Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

P. Dehghani, Varun Srivatsav, O. Vardeny, et al. (2024). JACC: Advances. Cited 2 times. https://doi.org/10.1016/j.jacadv.2024.100897